More on NGNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurogene (NQ:NGNE)
Delayed: 29.10 +0.10 (0.34%)
Prev. Close $29.00  
Open$29.08 
52 Wk High$ 
52 Wk Low$ 
Day High$29.76 
Day Low$28.20 
P/E N/A  
EPS$ 
Volume112,542 

Friends, Peers and Foes (?): TSHA, BMRN, DNLI, DYN, LXEO (more...)

Jun 9, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Jun 8, 2026 07:33 AM Form 8-K Neurogene Inc. For: Jun 08
Jun 8, 2026 07:31 AM Neurogene completes dosing in gene therapy trial for Rett syndrome
Jun 8, 2026 07:30 AM Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
Jun 4, 2026 04:41 PM Form 8-K Neurogene Inc. For: Jun 03
Jun 3, 2026 06:42 AM Rodman & Renshaw Starts Neurogene (NGNE) at Buy, PT $70
Jun 2, 2026 04:01 PM Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2026 09:42 AM Neurogene (NGNE) PT Raised to $65 at Craig-Hallum
May 12, 2026 05:28 PM Neurogene (NGNE) Misses Q1 EPS by 139c
May 12, 2026 04:07 PM Form 8-K Neurogene Inc. For: May 12
View All Articles

Entities mentioned with NGNE

View All Entities